Advertisement

Topics

AstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast Cancer

07:31 EST 15 Nov 2017 | RTTNews

British drug maker AstraZeneca plc (AZN.L, AZN) said that the US Food and Drug Administration or FDA has approved a new indication for Faslodex or fulvestrant, expanding the indication to include use with abemaciclib.

Original Article: AstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...